Joey CohenMedication Adherence
Stacey GandlerBrand Nourishment
Frank BurrellScientific Storytelling
Brenda SnowAuthentic Patient Voice
Bud BilanichSuccess Coach
Pat PurcellMeeting Engagement
Matt TurnerPatient Affordability
Daniel SontupeMarket Access
Matthew DurhamOmnidynamic Marketing
Paul TheisenPatient Acquisition
Liz KaneImpactful Strategy
Suma Ramadas, PhDMedical Affairs
Amy GilesIncreasing Engagement
David LinetskyPoint-of-Care Marketing
Phase 1 Study of PARP Inhibitor 2X-121 Selected as Oral Presentation June 1, 2018HOERSHOLM, ...
NEWTOWN, Pa., July 19, 2016 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a Phase ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email